This PhD student blog post explores the use of machine learning for simultaneously optimizing antibody affinity and specificity, which could help accelerate drug development.
Peter Tessier
Behind the Paper: Enabling Multi-Objective Antibody Optimization
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
The method could one day be used to develop nanobodies against other viruses and disease targets as well.
